FIELD: organic chemistry. SUBSTANCE: product: derivatives of N-phenylglycine amide of the general formula (I): R4-H(CHR1COR2)-COCH2NHCOR3 where: R4-H(CHR1COR2)-COCH2NHCOR3 - hydrogen, (lower) alkyl; R1 - (lower) alkoxy or R2; NR5R3 - quinolyl or phenylamino-group where phenyl is substituted with one or some substituents taken from halogen, lower alkyl, (lower) alkylthio-group, carboxyl, monooxy(lower)alkyl, (lower)alkoxycarbonyl, oxyimino(lower)alkyl, tetrazolyl-5-(lower)alkyl, (lower)alkyl-COOX, -O-(lower)alkyl-COOX, -CH=CHCOOH, (lower)alkyl-R3; X - hydrogen, lower alkyl; SO3H - phenyl substituted with halide, (lower)alkyl, (lower)alkoxy, hydroxyl; polyfluoro(lower)alkyl or (lower)alkoxy, R4, (lower)alkylthio, (lower)alkoxycarbonyl, carboxyl, acylamino, methylenedioxy, trifluoromethylthio, phenoxy, phenyl, di-(lower)-alkylamino or CON-NO2 where: RaRв - lower alkyl, Ra - phenyl, or Rв and Ra together with nitrogen to which they were bound form: 1,2,3,4-tetrahydroquinolyl-1-, 3.3-di-(lower)-alkylpiperidine, 3,4-dihydro-2H-benzoxazine or morpholine cycle; Rв - (lower)alkyl; R5 - phenyl possibly substituted with halide; or R6 and R5 together with nitrogen atom to which they were bound form: 3,3-di-(lower)-alkylpiperidine cycle, 3,4-dihydro-2H-benzothiazine-1.4-cycle, 1,2,3,4-tetrahydroquinolyl-1-cycle. Reagent 2: isocyanate: OCN-R6. Reagent 3: amino-derivative: R9 - R4-CO-N[CH(R1)COR2]. Synthesized product if necessary is hydrolyzed; compound (I) -CH2-NH2 is isolated as ester or in the free form. If (I) R4-H(CHR1COR2)-COCH2NHCOR3 has R4-H(CHR1COR2)-COCH2NHCOR3 - phenylamino-radical with substituted phenyl ring then the corresponding ester is hydrolyzed. If (I) R3 has R4-H(CHR1COR2)-COCH2NHCOR3 - phenyl substituted with hydroxy-group then the corresponding compound (I) R4 where R4-H(CHR1COR2)-COCH2NHCOR3 - phenyl substituted with lower alkoxy-group is hydrolyzed. Pharmacological composition showing affinity to receptors R4 and gastrin contains compound (I) R4-H(CHR1COR2)-COCH2NHCOR3 as an active substance at a single dose 10-500 mg. Synthesized compounds were used in biology and medicine. EFFECT: improved method of synthesis. 7 cl, 2 tbl
Authors
Dates
1997-03-27—Published
1991-03-05—Filed